Literature DB >> 30731459

Diabetes Mellitus and Age are Risk Factors of Interval Colon Cancer: A Case-Control Study.

Ido Laish1,2, Joseph Mizrahi3,4, Timna Naftali3,5, Fred M Konikoff3,5.   

Abstract

BACKGROUND AND AIMS: Interval colorectal cancer (CRC) is largely related to a poor endoscopic performance or different biology in the development of the polyp. However, patient-related factors were less investigated for their association with interval cancer. We thus evaluated tumor and patient characteristics as predictors of interval cancer in a population from Israel.
METHODS: In this retrospective study, patients that were diagnosed with colon cancer in our institution and had 2 colonoscopies were included. Demographic parameters and tumor characteristics were compared between 84 cases with interval cancer, occurring 1-10 years after a negative colonoscopy, and 983 patients with primary CRC. In addition, patient-related features, including diabetes and diverticulosis, were compared between 51 patients with interval cancer after negative colonoscopy and 255 controls with no cancer and a previous negative colonoscopy.
RESULTS: Compared to "positive" controls with primary cancer, patients with interval cancer were older (age 71.3 vs. 67.6, p = 0.003), had proximal tumor location (57 vs. 34%, p < 0.001) and non-advanced (0-2) tumor staging (78.5 vs. 64.8%, p = 0.014). Compared with -"negative" healthy controls, cases with interval cancer had only higher prevalence of diabetes (31 vs. 15%, p = 0.002). No significant differences were seen between patients with interval cancer occurring < 3 years and after 3-10 years.
CONCLUSIONS: Patients with Interval cancer tend to be older and have diabetes. These patient groups should be more carefully or more frequently screened for pre-malignant lesions.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Interval colon cancer; Predictors

Mesh:

Year:  2019        PMID: 30731459     DOI: 10.1159/000496740

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  2 in total

1.  Effect of bevacizumab on expression level of GLI1 and ING4 in colon cancer animal model.

Authors:  Bing Suo; Caiyu Wu; Fen Mei
Journal:  Oncol Lett       Date:  2020-05-28       Impact factor: 2.967

Review 2.  Utility of KRAS Gene and Clinicopathological Features in the Assessment of the Risk of Type 2 Diabetes in the Etiology of Colon Cancer.

Authors:  Wedad Saeed Al-Qahtani; Ebtesam Al-Olayan; Fatimah Gh Albani; Rania Saad Suliman; Nada Hamad Aljarba; E M Al-Humaidhi; Alanood S Almurshedi; Dalia Mostafa Domiaty; Manal Abdullah Alduwish; Aljohara M Al-Otaibi; Abdelbaset Mohamed Elasbali; Hussain Gadelkarim Ahmed; Bassam Ahmed Almutlaq
Journal:  Glob Med Genet       Date:  2020-08-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.